CTRI/2024/09/073960招募中Unknown
Efficacy and Safety of Ashwagandha (Withania Somnifera) Root Extract on Muscle Strength and Endurance In Healthy Athletes: A Prospective, Randomized, Double-BUnd, Placebo-Controlled Study
试验速览
- 阶段
- Unknown
- 状态
- 招募中
- 入组人数
- 120
- 试验地点
- 1
- 主要终点
- To evaluate the effects of KSM-66 Ashwagandha formulations on muscle recovery (Delayed-Onset Muscle Soreness (DOMS)) using 0-10 Visual Analog Scale (VAS).
研究概览
简要总结
- All eligible subjects who meet the Inclusion and Exclusion criteria will be part of the study
- Subjects will be informed about the purpose of the study and signed informed consent will be taken.
- Blood sampling for efficacy and safety parameters will be done at visit 1 (screening visit/ enrolment visit/ baseline visit- day 1) and visit 3 (week 8).
- All subjects will be followed-up during the study period (visit 1 (screening visit/ enrolment visit/ baseline visit- day 1), visit 2 (week 4- Telephonic) ± 4 days, and visit 3 (week 8) ± 4 days.
- The Adverse events, either spontaneously reported by the patient, or noticed by the clinician will be recorded during the study.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 盲法
- Participant and Outcome Assessor Blinded
入排标准
- 年龄范围
- 18.00 Year(s) 至 45.00 Year(s)（—）
- 性别
- All
入选标准
- •1.Male and female subjects with age from 18 to 45 years who are healthy athletes
- •Ability to understand the risks and benefits of the protocol
- •Subject with a history of gymnasium visits since the last three months of screening
- •Subject willing to follow the same exercise and diet regime for the study period as prescribed by the study protocol
- •Subject who has given written informed consent to participate in the study and understand the nature of the study
- •Able to read and write in English or any other vernacular language
- •No plan to commence new treatments over the study period.
- •Must have the ability and willingness to sign an informed consent and to comply with all study procedures.
排除标准
- •1.Participants taking any form of herbal extract in the last 3 months before study entry.
- •2.Any history of drug abuse, smoking 10+ cigarettes a day or consuming more than 14 grams of alcohol daily, 3.Subjects planning to participate in any Sports event during the study period 4.Weight loss of greater than 5kg in the past 3 months 5.History of any orthopedic injury or surgery in the past 6 months 6.Subject diagnosed with heart disease, diabetes, stroke, or other neurological disorders or depression 7.Subject with significant medication use (blood pressure, beta-blockers, inhaled beta-agonists, hormonal contraceptives, corticosteroid use within the prior three months, psychotropic medication use within the prior eight weeks) 8.Subjects with a history of any prohibited drug use 9.Participants with evidence of uncooperative attitude, including poor compliance.
- •10.Participants with inability to attend follow-up visit 11.Participants with any other medical condition (for example uncontrolled infection) that may, in the opinion of the Investigator, interfere with the study objective.
- •12.Patients with known hypersensitivity to Ashwagandha.
- •13.Patients who had participated in other clinical trials during the previous 3 months.
- •14.Patients who have any clinical condition, according to the investigator who does not allow safe fulfilment of clinical trial protocol.
结局指标
主要结局
To evaluate the effects of KSM-66 Ashwagandha formulations on muscle recovery (Delayed-Onset Muscle Soreness (DOMS)) using 0-10 Visual Analog Scale (VAS).
时间窗: Baseline, Week 8
次要结局
- To evaluate the effects of KSM-66 Ashwagandha formulations on cardiorespiratory endurance (time to exhaustion using the Bruce Protocol) using motorized treadmill.(Baseline, Week 8)
- To evaluate the effects of KSM-66 Ashwagandha formulations on measurement in arm circumference (muscle size).(Baseline, Week 8)
- To evaluate the effects of KSM-66 Ashwagandha formulations on change in body-composition using Bioelectrical Impedance Analysis (BIA). [(Baseline, Week 8)
- To evaluate the effect of the KSM-66 Ashwagandha formulation on Quality of Life (QoL) using the Short Form-12 tool.(Baseline, Week 8)
- To evaluate the effects of KSM-66 Ashwagandha formulations on serum hormones (Sr. Creatinine kinase, Testosterone).(Baseline, Week 8)
- To evaluate the safety of KSM-66 Ashwagandha formulations on Liver (serum alanine transaminase, aspartate transaminase, alkaline phosphatase, bilirubin) parameters.(Baseline, Week 8)
- To evaluate the safety of KSM-66 Ashwagandha formulations on Renal (serum creatinine, blood urea nitrogen) parameters(Baseline, Week 8)
- To evaluate the safety of KSM-66 Ashwagandha formulations on Treatment-Emergent Adverse Events (TEAE)/ Treatment-Emergent Serious Adverse Events (TESAE).(Baseline, Week 4, Week 8)
研究者
DrAnup Krishnan J
D Y Patil Hospital,Nerul
研究点 (1)
Loading locations...
相似试验
尚未招募
不适用
Effectiveness of ashwagandha in pregnant womenCTRI/2025/01/079238Ixoreal Biomed Private Limited70
招募中
4 期
Ashwagandha for Post-Menopausal Health: A Clinical StudyCTRI/2024/04/065706Simran Obhrai60
招募中
3 期
TO COMPARE THE EFFICACY OF ASHWAGANDHADYA GHRITA PANA AND NASYA ALONG WITH RASNAPANCHAK KWATHA AND GUGGULU VATI IN THE MANAGEMENT OF CERVICAL SPONDYLOSISCTRI/2025/03/083350NATIONAL INSTITUTE OF AYURVEDA DEEMED TO BE UNIVERSITY DEEMED TO BE UNIVESRITY JAIPUR40
招募中
2 期
A clinical trial of Aswagandha and Shilajit in male sexual dysfunction due to mild to moderate stress disordersCTRI/2024/12/078369Sakti Naturals Pvt. Ltd90
已完成
Phase 3 4
Clinical trial on muscle endurance in healthy male volunteersCTRI/2025/03/083139Ingex Botanicals Private Limited60